The impact of routine utilization of two assessment scales on management of antipsychotic-induced side effects

ISRCTN ISRCTN88391730
DOI https://doi.org/10.1186/ISRCTN88391730
Secondary identifying numbers N0146155662
Submission date
30/09/2005
Registration date
30/09/2005
Last edited
25/04/2014
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Mental and Behavioural Disorders
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr Albert Ngan
Scientific

Homerton Hospital NHS Trust
Homerton Row
London
E9 6SR
United Kingdom

Study information

Study designRandomised controlled trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Not specified
Study typeNot Specified
Scientific title
Study objectivesTo identify the effects of introduction of two assessment scales to regularly appraise antipsychotic-induced side effects in forensic psychiatric patients on management of these side effects and patients' clinical outcome.
Ethics approval(s)Not provided at time of registration
Health condition(s) or problem(s) studiedMental and Behavioural Disorders: Psychosis
InterventionTwo assessment scales
Intervention typeOther
Primary outcome measureChanges/differences in the scales ratings at the baseline and the end-assessment within the control and study group and between groups. Differences in the general mental health rating at the beginning and the end-assessment between the control and the study groups. Associations between side effects assessment and the general mental health status.
Secondary outcome measuresNot provided at time of registration
Overall study start date01/10/2003
Completion date30/04/2004

Eligibility

Participant type(s)Patient
Age groupNot Specified
SexNot Specified
Target number of participants30 (study) and 30 (control) patients
Key inclusion criteria30 (study) and 30 (control) patients in the Forensic Mental Health Unit, Homerton
Key exclusion criteriaNot provided at time of registration
Date of first enrolment01/10/2003
Date of final enrolment30/04/2004

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Homerton Hospital NHS Trust
London
E9 6SR
United Kingdom

Sponsor information

Department of Health
Government

Richmond House
79 Whitehall
London
SW1A 2NL
United Kingdom

Phone +44 (0)20 7307 2622
Email dhmail@doh.gsi.org.uk
Website http://www.dh.gov.uk/Home/fs/en

Funders

Funder type

Government

East London and The City Mental Health NHS Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan